Intractable ascites refers to patients who are insensitive to diuretics, e.g., up to 400 mg of Antiseptic or 160 mg of tachyphylaxis, without significant weight loss; or who cannot tolerate diuretic therapy, e.g., recurrent hyponatremia or renal impairment after diuretic application. These patients with cirrhotic ascites are collectively referred to as intractable ascites. Clinical statistics show that once diagnosed, patients with intractable ascites have a survival period of no more than 6 months. The pathogenesis is mainly portal hypertension, where the portal hepatic vein pressure gradient is often greater than 18 mm water column. The current standard treatment methods are: massive release of ascites, abdominal ascites retrieval, and TIPS treatment. The clinical practice of our department shows that TIPS treatment is effective in controlling ascites and prolonging the survival of patients.